カテゴリー： QYResearch, 世界

世界の2型糖尿病薬市場 2019年

【英語タイトル】Global Type 2 Diabetes Therapeutics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16985）・商品コード：DATA909X16985
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、2型糖尿病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、DPP-4阻害剤、ビグアナイド剤、インスリン、GLP-1受容体アゴニスト、チアゾリデンジオン、スルホン尿素、SGLT-2阻害剤、A-グルコシダーゼ阻害剤、その他に、用途別には、病院薬局、小売薬局、オンライン薬局、その他にセグメント区分し、2型糖尿病薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・2型糖尿病薬の世界市場概要
・2型糖尿病薬の製造コスト構成分析
・2型糖尿病薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・2型糖尿病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・2型糖尿病薬のセグメント分析（種類別）
（DPP-4阻害剤、ビグアナイド剤、インスリン、GLP-1受容体アゴニスト、チアゾリデンジオン、スルホン尿素、SGLT-2阻害剤、A-グルコシダーゼ阻害剤、その他）
・2型糖尿病薬のセグメント分析（用途別）
（病院薬局、小売薬局、オンライン薬局、その他）
・2型糖尿病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AstraZeneca、Novartis、Novo Nordisk、Boehringer Ingelheim、Bristol-Myers Squibb、Eli Lilly、Merck、Sanofi、Astellas Pharma、Daiichi Sankyo、Biocon、）
・2型糖尿病薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Type 2 Diabetes Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Type 2 Diabetes Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type 2 Diabetes Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Type 2 Diabetes Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Type 2 Diabetes Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Astellas Pharma
Daiichi Sankyo
Biocon

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
DPP-4 inhibitors
Biguanides
Insulins
GLP-1 receptor agonists
Thiazolidenediones
Sulfonulureas
SGLT-2 inhibitors
A-Glucosidase inhibitors
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Type 2 Diabetes Therapeutics
1.1 Definition of Type 2 Diabetes Therapeutics
1.2 Type 2 Diabetes Therapeutics Segment by Type
1.2.1 Global Type 2 Diabetes Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 DPP-4 inhibitors
1.2.3 Biguanides
1.2.4 Insulins
1.2.5 GLP-1 receptor agonists
1.2.6 Thiazolidenediones
1.2.7 Sulfonulureas
1.2.8 SGLT-2 inhibitors
1.2.9 A-Glucosidase inhibitors
1.2.10 Others
1.3 Type 2 Diabetes Therapeutics Segment by Applications
1.3.1 Global Type 2 Diabetes Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Type 2 Diabetes Therapeutics Overall Market
1.4.1 Global Type 2 Diabetes Therapeutics Revenue (2014-2025)
1.4.2 Global Type 2 Diabetes Therapeutics Production (2014-2025)
1.4.3 North America Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)
1.4.5 China Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)
1.4.8 India Type 2 Diabetes Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Type 2 Diabetes Therapeutics
2.3 Manufacturing Process Analysis of Type 2 Diabetes Therapeutics
2.4 Industry Chain Structure of Type 2 Diabetes Therapeutics

3 Development and Manufacturing Plants Analysis of Type 2 Diabetes Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Type 2 Diabetes Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Type 2 Diabetes Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Type 2 Diabetes Therapeutics Production and Capacity Analysis
4.2 Type 2 Diabetes Therapeutics Revenue Analysis
4.3 Type 2 Diabetes Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Type 2 Diabetes Therapeutics Regional Market Analysis
5.1 Type 2 Diabetes Therapeutics Production by Regions
5.1.1 Global Type 2 Diabetes Therapeutics Production by Regions
5.1.2 Global Type 2 Diabetes Therapeutics Revenue by Regions
5.2 Type 2 Diabetes Therapeutics Consumption by Regions
5.3 North America Type 2 Diabetes Therapeutics Market Analysis
5.3.1 North America Type 2 Diabetes Therapeutics Production
5.3.2 North America Type 2 Diabetes Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Type 2 Diabetes Therapeutics Import and Export
5.4 Europe Type 2 Diabetes Therapeutics Market Analysis
5.4.1 Europe Type 2 Diabetes Therapeutics Production
5.4.2 Europe Type 2 Diabetes Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Type 2 Diabetes Therapeutics Import and Export
5.5 China Type 2 Diabetes Therapeutics Market Analysis
5.5.1 China Type 2 Diabetes Therapeutics Production
5.5.2 China Type 2 Diabetes Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Type 2 Diabetes Therapeutics Import and Export
5.6 Japan Type 2 Diabetes Therapeutics Market Analysis
5.6.1 Japan Type 2 Diabetes Therapeutics Production
5.6.2 Japan Type 2 Diabetes Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Type 2 Diabetes Therapeutics Import and Export
5.7 Southeast Asia Type 2 Diabetes Therapeutics Market Analysis
5.7.1 Southeast Asia Type 2 Diabetes Therapeutics Production
5.7.2 Southeast Asia Type 2 Diabetes Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Type 2 Diabetes Therapeutics Import and Export
5.8 India Type 2 Diabetes Therapeutics Market Analysis
5.8.1 India Type 2 Diabetes Therapeutics Production
5.8.2 India Type 2 Diabetes Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Type 2 Diabetes Therapeutics Import and Export

6 Type 2 Diabetes Therapeutics Segment Market Analysis (by Type)
6.1 Global Type 2 Diabetes Therapeutics Production by Type
6.2 Global Type 2 Diabetes Therapeutics Revenue by Type
6.3 Type 2 Diabetes Therapeutics Price by Type

7 Type 2 Diabetes Therapeutics Segment Market Analysis (by Application)
7.1 Global Type 2 Diabetes Therapeutics Consumption by Application
7.2 Global Type 2 Diabetes Therapeutics Consumption Market Share by Application (2014-2019)

8 Type 2 Diabetes Therapeutics Major Manufacturers Analysis
8.1 AstraZeneca
8.1.1 AstraZeneca Type 2 Diabetes Therapeutics Production Sites and Area Served
8.1.2 AstraZeneca Product Introduction, Application and Specification
8.1.3 AstraZeneca Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Type 2 Diabetes Therapeutics Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novo Nordisk
8.3.1 Novo Nordisk Type 2 Diabetes Therapeutics Production Sites and Area Served
8.3.2 Novo Nordisk Product Introduction, Application and Specification
8.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Boehringer Ingelheim
8.4.1 Boehringer Ingelheim Type 2 Diabetes Therapeutics Production Sites and Area Served
8.4.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production Sites and Area Served
8.5.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly
8.6.1 Eli Lilly Type 2 Diabetes Therapeutics Production Sites and Area Served
8.6.2 Eli Lilly Product Introduction, Application and Specification
8.6.3 Eli Lilly Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Merck
8.7.1 Merck Type 2 Diabetes Therapeutics Production Sites and Area Served
8.7.2 Merck Product Introduction, Application and Specification
8.7.3 Merck Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Sanofi
8.8.1 Sanofi Type 2 Diabetes Therapeutics Production Sites and Area Served
8.8.2 Sanofi Product Introduction, Application and Specification
8.8.3 Sanofi Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Astellas Pharma
8.9.1 Astellas Pharma Type 2 Diabetes Therapeutics Production Sites and Area Served
8.9.2 Astellas Pharma Product Introduction, Application and Specification
8.9.3 Astellas Pharma Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Daiichi Sankyo
8.10.1 Daiichi Sankyo Type 2 Diabetes Therapeutics Production Sites and Area Served
8.10.2 Daiichi Sankyo Product Introduction, Application and Specification
8.10.3 Daiichi Sankyo Type 2 Diabetes Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Biocon

9 Development Trend of Analysis of Type 2 Diabetes Therapeutics Market
9.1 Global Type 2 Diabetes Therapeutics Market Trend Analysis
9.1.1 Global Type 2 Diabetes Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Type 2 Diabetes Therapeutics Regional Market Trend
9.2.1 North America Type 2 Diabetes Therapeutics Forecast 2019-2025
9.2.2 Europe Type 2 Diabetes Therapeutics Forecast 2019-2025
9.2.3 China Type 2 Diabetes Therapeutics Forecast 2019-2025
9.2.4 Japan Type 2 Diabetes Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Type 2 Diabetes Therapeutics Forecast 2019-2025
9.2.6 India Type 2 Diabetes Therapeutics Forecast 2019-2025
9.3 Type 2 Diabetes Therapeutics Market Trend (Product Type)
9.4 Type 2 Diabetes Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Type 2 Diabetes Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Type 2 Diabetes Therapeutics
Table Global Type 2 Diabetes Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Type 2 Diabetes Therapeutics Production Market Share by Types in 2018
Figure DPP-4 inhibitors Product Picture
Figure Biguanides Product Picture
Figure Insulins Product Picture
Figure GLP-1 receptor agonists Product Picture
Figure Thiazolidenediones Product Picture
Figure Sulfonulureas Product Picture
Figure SGLT-2 inhibitors Product Picture
Figure A-Glucosidase inhibitors Product Picture
Figure Others Product Picture
Table Global Type 2 Diabetes Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Type 2 Diabetes Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacies
Figure Online Pharmacy
Figure Others
Figure Global Type 2 Diabetes Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Type 2 Diabetes Therapeutics Production (K Units) (2014-2025)
Figure North America Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Figure China Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Figure India Type 2 Diabetes Therapeutics Market Size (Million USD) (2014-2025)
Table Type 2 Diabetes Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Type 2 Diabetes Therapeutics in 2018
Figure Manufacturing Process Analysis of Type 2 Diabetes Therapeutics
Figure Industry Chain Structure of Type 2 Diabetes Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Type 2 Diabetes Therapeutics Manufacturing Plants Distribution
Table Type 2 Diabetes Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Type 2 Diabetes Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Type 2 Diabetes Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Type 2 Diabetes Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Type 2 Diabetes Therapeutics Production Share by Manufacturers in 2018
Table Type 2 Diabetes Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Type 2 Diabetes Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Type 2 Diabetes Therapeutics Revenue Share by Manufacturers in 2018
Table Type 2 Diabetes Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Type 2 Diabetes Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Type 2 Diabetes Therapeutics Production Market Share by Regions 2014-2019
Figure Global Type 2 Diabetes Therapeutics Production Market Share by Regions in 2018
Table Global Type 2 Diabetes Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Regions in 2018
Table Global Type 2 Diabetes Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Type 2 Diabetes Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure China Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure India Type 2 Diabetes Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Type 2 Diabetes Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Type 2 Diabetes Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Type 2 Diabetes Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Type 2 Diabetes Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Type 2 Diabetes Therapeutics Production Sites and Area Served
Table AstraZeneca Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table AstraZeneca Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table AstraZeneca Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure AstraZeneca Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table AstraZeneca Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Novartis Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Novartis Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Novartis Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Novartis Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Novartis Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Novartis Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Novo Nordisk Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Novo Nordisk Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Novo Nordisk Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Novo Nordisk Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Novo Nordisk Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Novo Nordisk Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Boehringer Ingelheim Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Eli Lilly Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Eli Lilly Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Eli Lilly Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Eli Lilly Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Eli Lilly Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Eli Lilly Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Merck Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Merck Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Merck Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Merck Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Merck Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Merck Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Sanofi Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Sanofi Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Sanofi Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Sanofi Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Sanofi Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Sanofi Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Astellas Pharma Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Astellas Pharma Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Astellas Pharma Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Astellas Pharma Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Astellas Pharma Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Astellas Pharma Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Production Sites and Area Served
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Product Introduction, Application and Specification
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Production Growth Rate (2014-2019)
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Production Market Share (2014-2019)
Figure Daiichi Sankyo Type 2 Diabetes Therapeutics Revenue Market Share (2014-2019)
Table Daiichi Sankyo Type 2 Diabetes Therapeutics Main Business and Markets Served
Table Biocon Type 2 Diabetes Therapeutics Production Sites and Area Served
Figure Global Type 2 Diabetes Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Type 2 Diabetes Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Type 2 Diabetes Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Type 2 Diabetes Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Type 2 Diabetes Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Type 2 Diabetes Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Type 2 Diabetes Therapeutics by Application (2019-2025)
Table Type 2 Diabetes Therapeutics Distributors List
Table Type 2 Diabetes Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca、Novartis、Novo Nordisk、Boehringer Ingelheim、Bristol-Myers Squibb、Eli Lilly、Merck、Sanofi、Astellas Pharma、Daiichi Sankyo、Biocon、

★調査レポート[世界の2型糖尿病薬市場 2019年] (コード：DATA909X16985)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の2型糖尿病薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の1型糖尿病薬市場 2019年
    DATA909X16984 / QYResearch / 2019年11月22日 / ※本調査レポートは、1型糖尿病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、その他に、用途別には、ドラッグストア、病院、その他にセグメント区分し、1型糖尿病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・1型糖尿病薬の世界市場概要 ・1型糖尿病薬の製造コスト構成分析 ・1型糖尿病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・1型糖尿病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・1型糖尿病薬のセグメント分析（種類別） （インスリン、その他）...The global Type 1 Diabetes Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Type 1 Diabetes Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type 1 Diabetes Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Type 1 Diabetes Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の糖尿病用非インスリン療法市場 2019年
    DATA909X12070 / QYResearch / 2019年11月20日 / ※本調査レポートは、糖尿病用非インスリン療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アルファグルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4（DPP4）阻害剤、グリニド/メグリチニド、GLP-1アナログ/ GLP-1アゴニスト、ナトリウム-グルコース共輸送体2（SGLT2）阻害剤、スルフォニル尿素、チアゾリジンジオン、その他に、用途別には、病院薬局、小売薬局、オンライン薬局、その他にセグメント区分し、糖尿病用非インスリン療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・糖尿病用非インスリン療法の世界市場概要 ・糖尿病用非インスリン療法の製造コスト構成分析 ・糖尿病用非インスリン療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・糖尿病用非インスリン療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・糖尿病用非インスリン療法のセグメント分析（種類別）...The global Non-Insulin Therapies for Diabetes market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Insulin Therapies for Diabetes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Insulin Therapies for Diabetes market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Non-Insulin Therapies for Diabetes in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の糖尿病ケア製品市場 2019年
    DATA909X06383 / QYResearch / 2019年11月15日 / ※本調査レポートは、糖尿病ケア製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、糖尿病検査製品、インスリンポンプ、糖尿病アクセサリー、糖尿病フットケア、インスリンシリンジに、用途別には、医療、パーソナルケアにセグメント区分し、糖尿病ケア製品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・糖尿病ケア製品の世界市場概要 ・糖尿病ケア製品の製造コスト構成分析 ・糖尿病ケア製品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・糖尿病ケア製品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・糖尿病ケア製品のセグメント分析（種類別） （糖尿病検査製品、インスリンポンプ、糖尿病アクセサリー、糖尿病フットケア、インスリンシリンジ）...The global Diabetes Care Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Diabetes Care Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Care Products market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Diabetes Care Products in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆